Schedule of Deferred Taxes (Details) (Parenthetical) - Chemomab Therapeutics Ltd [Member] $ in Thousands |
Dec. 31, 2025
USD ($)
|
|---|---|
| Tax credit carryforward valuation allowance | $ 14,223 |
| Amount of benefit of deferred tax assets offset by a valuation allowance | $ 544 |